To test the idea.

To test the idea, the researchers recruited 82 women, of course with breast cancer of whom 35 were. About two thirds of the women had children, and had given birth to more than half of of the participants at least given a son. The researchers took blood samples from each participant and searched them for male DNA, as it is a relatively definite matter of the male Y chromosome amid the mother home and, of course, recognize female cells in a blood sample justified.

Long-term residence ‘Could A Hidden connection between childbirth and a reduced risk of breast cancer beSome benefits of motherhood are intangible, but it by through biostatistical research: women who bear children have to suffer a lower risk of breast cancer. In Seattle, Washington, researchers believe in the University of Washington and Fred Hutchinson Cancer Research Center have a source of a source of this protective effect: fetal cells ‘transplanted’to the mother before birth.– ‘The risk of the complication – said Maria Benedetta Donati, is relatively high and Coordinator at the Research Laboratory of the is relatively high, and the analysis of affected children characteristics properties is us order to identify individuals at high risk in this way. Data immediately for haematologist, best therapies to take the best therapies, after of genetic predisposition the individual child. ‘.. Data was selected of 17 international trials according to strict scientific tests Invite getroffen.2 % of all children reports thrombotic complications. Researchers have various factors in determining risk for them complication to identify. In particular, many of the thrombotic events has occurred during the ‘induced ‘phase of the antileukemic treatment.

Catholic University to children with leukemiaHelping researchers and physicians more understood and from those most suitable instruments, a serious complication that occur in children affected from acute lymphoblastic leukemia : of thrombosis, say blood vessel occlusion through the blood blood clots that most common cause of myocardial infarction, pulmonary embolism and others cardiovascular diseases. It is the product of a research project in Italy by the lab to genetic and environmental epidemiology of and which onco – Haematology unity of the Catholic University, collaboration with collaboration with the hematology Division of the University of L’Aquila.